BioSight Ltd.
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- BioSight Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT05503355
- Locations
- ๐บ๐ธ
Northwestern Memorial Hospital, Chicago, Illinois, United States
๐บ๐ธThe University of Texas MD Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธUniversity of Virginia Cancer Center, Charlottesville, Virginia, United States
Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS
- Conditions
- Interventions
- First Posted Date
- 2021-02-11
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- BioSight Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04749355
- Locations
- ๐บ๐ธ
Seattle Cancer Care Alliance, Seattle, Washington, United States
๐บ๐ธOchsner LSU Health Shreveport - Academic Medical Center, Shreveport, Louisiana, United States
๐บ๐ธUniversity of Virginia Cancer Center, Charlottesville, Virginia, United States
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- BioSight Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT03435848
- Locations
- ๐บ๐ธ
Abramson Cancer Center, Philadelphia, Pennsylvania, United States
๐ฎ๐ฑRambam medical center hematology department, Haifa, Israel
๐บ๐ธBaylor Scott & White Research Institute Dallas Texas, Dallas, Texas, United States
Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2017-09-27
- Lead Sponsor
- BioSight Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02544438
- Locations
- ๐ฎ๐ฑ
Rambam medical center hematology department, Haifa, Israel
๐ฎ๐ฑTel Aviv Sourasky Medical Center, Tel Aviv, Israel